
Benzinga Pro data, LifeMD (NASDAQ:LFMD) reported Q4 sales of $27.42 million. Earnings fell to a loss of $18.01 million, resulting in a 24.91% decrease from last quarter. LifeMD collected $24.95 million in revenue during Q3, but reported earnings showed a $14.42 million loss.